Besides their special organization in lipid domains (lipid rafts) of the membrane lipid bilayers, some sphingolipids, e.g., ceramides, sphingosine, and sphingosine-1-phosphate have been described to function as lipid-derived second messengers mainly regulating fundamental cellular pathways such as apoptosis and differentiation [119, 120]
"GDF8 and activin A blockade protects against GLP-1induced muscle loss while enhancing fat loss in obese male mice and non-human primates." Nature Communications 16.1 (2025): 1-8
Before committing to compounded medications, check whether your insurance covers Wegovy, Mounjaro, or Zepbound
"Glutathione gip da chng li qu trnh lo ha v tc hi ca mi trng nh nhim, nh nng mt tri v khi thuc, ng thi h tr lm gim sn xut melanin, mang li ln da sng u mu hn." Bn cnh , glutathione cn c khoa hc chng minh mang li nhiu li ch v sc khe nh: H tr ci thin cc bnh l da nh vy nn
Both semaglutide and tirzepatide are effective for weight loss, but studies show that tirzepatide (Mounjaro, Zepbound, etc) generally causes more weight loss than semaglutide (Ozempic, Wegovy, etc) due to its added GIP receptor activity in addition to GLP1
Let's hope Teva comes up with a cool name for this one #obesity #diabetes #biosimilar #generic #biotechindustry #pharma Thanks for sharing, it will be interesting to see if cost is prioritized over efficacy and convenience, and how Teva positions its daily Saxenda generic in a market dominated by next-gen weekly GLP-1s